Current Status: Site-Specific Antibody Drug Conjugates-Reference-Cited by-同舟云学术

Current Status: Site-Specific Antibody Drug Conjugates

Published:2016-03-22 Issue:S1 Volume:36 Page:100-107
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

Schumacher Dominik,Hackenberger Christian P. R.,Leonhardt Heinrich,Helma Jonas^ORCID

Funder

Deutsche Forschungsgemeinschaft

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s10875-016-0265-6.pdf

Reference62 articles.

1. Agarwal P, Bertozzi CR. Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development. Bioconjug Chem. 2015. doi: 10.1021/bc5004982 .

2. Chari RV, Miller ML, Widdison WC. Antibody-drug conjugates: an emerging concept in cancer therapy. Angew Chem Int Ed Engl. 2014;53:3796–827. doi: 10.1002/anie.201307628 .

3. Sochaj AM, Swiderska KW, Otlewski J. Current methods for the synthesis of homogeneous antibody-drug conjugates. Biotechnol Adv. 2015;33:775–84. doi: 10.1016/j.biotechadv.2015.05.001 .

4. Polakis P Antibody drug conjugates for cancer therapy. Pharmacol Rev. 2016;68:3–19. doi: 10.1124/pr.114.009373 .

5. Mathur R, Weiner GJ. Picking the optimal target for antibody-drug conjugates. Am Soc Clin Oncol Educ Book. 2013. doi: 10.1200/EdBook_AM.2013.33.e103 .

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-drug conjugates for non-small cell lung cancer: Advantages and challenges in clinical translation;Biochemical Pharmacology;2024-08

2. Fármacos Anticorpos Monoclonais para o Tratamento do Câncer: uma Perspectiva Brasileira;Revista Brasileira de Cancerologia;2024-04-22

3. Site-specific Antibody-Nitric Oxide Conjugate HN02 Possesses Improved Antineoplastic and Safety Properties;Journal of Immunotherapy;2024-03-27

4. A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers;Molecular Cancer;2024-03-23

5. Antibody-Drug Conjugate Overview: a State-of-the-art Manufacturing Process and Control Strategy;Pharmaceutical Research;2024-02-17